Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4632]

FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer

FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer

A closed-loop drug-delivery system could improve chemotherapy

A closed-loop drug-delivery system could improve chemotherapy

New study points to racial and social barriers that block treatment for multiple myeloma

New study points to racial and social barriers that block treatment for multiple myeloma

Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering

Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Gene therapy is halting cancer. Can it work against brain tumors?

Gene therapy is halting cancer. Can it work against brain tumors?

Lower relapse risk in triple-negative breast cancer with high immune cell levels

Lower relapse risk in triple-negative breast cancer with high immune cell levels

Melanomas resist drugs by ‘breaking’ genes

Melanomas resist drugs by ‘breaking’ genes

New insight into combatting drug-resistant prostate cancer

New insight into combatting drug-resistant prostate cancer

AACR 2024: Proteogenomic signatures may help identify risk of prostate cancer progression in patients with African and European ancestries

AACR 2024: Proteogenomic signatures may help identify risk of prostate cancer progression in patients with African...

More from ecancer